2C-BpsychedelicempathogencommonA popular psychedelic in the phenethylamine">Phenethylamine family. Provides empathic experiences at lower doses and strong visual and psychedelic experiences at higher doses. Commonly used as a party drug as it is more clear-headed than most psychedelics. 2C-B has been in use since the early 1990s
2C-Tpsychedelicempathogenresearch chemicaltentativeA very rare psychedelic phenylethylamine, that is quite lovely.
2C-T-7research chemicalempathogenpsychedelicA relatively uncommon psychedelic phenethylamine">Phenethylamine and possible MAOI. Long lasting, an possesses an unpredictable dosage curve. Questionable safety in combination with most things.
3-MeOMCstimulanthabit formingempathogenA cathinone that has a short history of human use.
3-MMCstimulanthabit formingempathogenA euphoric stimulant similar to Mephedrone but said to lack much of the "magic." Never gained the same popularity. Slightly less potent.
4,4-DMARstimulantempathogenhabit formingtentativeVery closely related stimulant to Aminorex and Pemoline. Was sold as a designer drug for quite awhile under the brand name "Serotoni" has been linked to at least 31 deaths. It is a potent SNDRA.
4-AcO-MiPTtentativepsychedelicempathogenresearch chemicalA quite potent tryptamine that has be related to having "shroom-like" visuals. Yet without much bodyload. Very hydroscopic. Seems to be quite safe in dosing. Similar to the likes of 2C-B.
4-CBCstimulantresearch chemicalempathogenhabit formingIs a potentially very neurotoxic Cathinone. Obviously no scientic reports have been noted on the neurotoxicity or cardiotoxicity, so please move on with extreme caution.
4-FAstimulantresearch chemicalhabit formingempathogencommonAn empathogen commonly used in place of MDMA. Has about the same duration of empathogenic effects but a longer stimulant "tail."
4-FMAstimulantresearch chemicalhabit formingempathogenA stimulant with some empathogenic properties, and analogue of Methamphetamine with similar effects. Reported to be less effective than 2-FMA and related compounds. Little is known about the pharmacological effects of this compound.
4-FPPpsychedelicempathogententativestimulantA piperazine derivative that has been reported to have mild pyschedelic effects, and also empathogen qualities. It has been sold in many branded legal highs.
4-MTAresearch chemicalempathogententativeEmpathogen with very low chronic toxicity but high risk of acute harm due to mixed serotonin release and MAOI action. Reported to lack euphoria and rarely sold since being scheduled.
5-APBpsychedelicstimulantresearch chemicalempathogenhabit formingA triple monoamine reuptake inhibitor. This agonism for 5-HT2B makes it likely that 5-APB would be cardiotoxic with long term use, as seen in other 5-HT2B agonists such as fenfluramine and MDMA.
5-APDBstimulantpsychedelicresearch chemicalempathogenhabit formingAn entactogenic Amphetamine stimulant with similar structure and effects to MDMA. An analogue of MDA, it is a highly selective serotonin releaser but inhibits reuptake of serotonin (weakly), dopamine and norepinephrine.
5-APDIempathogenresearch chemicaltentativeAlso commonly known as IAP. A selective serotonin releasing agent with psychedelic and empathogenic properties. Users have often reported issues with the drug causing overheating and unwelcome bowel movements.
5-EAPBstimulantpsychedelicresearch chemicalempathogenhabit formingA empathogen sold as a replacement to 5-MAPB after it was banned in the UK, but said to be less enjoyable and never gained much popularity.
5-IAIstimulantpsychedelicresearch chemicalhabit formingempathogenA monoamine triple releaser first synthesised by David Nichols, possesses similar properties to MDMA. Probably neurotoxic in humans, however the extent of this is unclear.
5-ITstimulantpsychedelicresearch chemicalhabit formingempathogenAn empathogenic stimulant with a very long duration, prone to cause overheating and potentially quite dangerous. Related to αMT, though described as being less psychedelic and with much stronger stimulating effects.
5-MAPBpsychedelicstimulantresearch chemicalempathogenhabit formingAn empathogen structurally similar to MDMA. Typically more visual than MDMA. Often reported to be much less stimulating and more relaxing than most other stimulating empathogens. Less psychedelic than 6-APB. Much longer lasting than MDMA.
5-MAPDBstimulantpsychedelicresearch chemicalempathogenAn entactogenic drug with similar effects to MDMA, it is related to 5-MAPB. Likely to release serotonin and show neurotoxicity in the same way as MDMA
5-MeO-αMTstimulantpsychedelicresearch chemicalempathogenA long-acting psychedelic and entactogenic tryptamine, related to αMT. Very potent and may be sold on blotters. Possibly has been missold as LSD in the past, however this is uncommon. Possibly an MAOI.
5-MeO-DIBFempathogenresearch chemicaltentativeAn uncommon and new psychedelic drug related to tryptamine; the Benzofuran analogue of 5-MeO-DiPT. Probably a serotonin receptor partial agonist. Little history of human use.
5-MeO-DiPTpsychedelicresearch chemicalempathogen5-methoxy-di isopropyl tryptamine, also known as 'foxy', a psychedelic tryptamine related to DMT, which distorts visual and audio perception. Reported to have a heavy body load at high doses, it behaves similarly to other drugs of its class.
5-MeO-MiPTpsychedelicresearch chemicalempathogencommonA potent, stimulating psychedelic tryptamine, sometimes compared to 5-MeO-DiPT. Has an unusually strong body component and weak visual effects. Often said to be very empathogenic.
6-APBstimulantpsychedelicresearch chemicalempathogenhabit formingA stimulant, empathogen and analog of MDA. Typically more visual than MDMA or MDA, as well as having a much longer onset and duration. Users often report a slightly more psychedelic headspace as well. Commonly sold as an alternative to MDMA and MDA.
6-APDBstimulantpsychedelicresearch chemicalempathogenhabit formingA stimulant and entactogen related to MDMA and an analogue of MDA. Reported as being fairly psychedlic at higher doses. It is a triple monoamine reuptake inhibitor. Potent full agonist of serotonin 2B receptors.
6-EAPBstimulantpsychedelicresearch chemicalempathogenhabit formingA rare entactogen benzofuran structurally related to MDMA and 6-APB, though weaker in effects. the pharmacology of this compound is unclear. Likely to be a monoamine releaser, monoamine reuptake inhibitor or both.
6-MAPBstimulantpsychedelicresearch chemicalempathogenhabit formingEmpathogen drug that is structurally related to 6-APB and MDMA.
A-PIHPstimulantempathogenhabit formingresearch chemicaltentativeQuite new Pyrrolidine based stimulant of the cathinone class. Not very many reports. Probably has a very fast tolerance raise, and lack of effects over time.
αETpsychedelicstimulantresearch chemicaltentativeempathogenα-Ethyltryptamine, originally developed by Upjohn as an MAOI antidepressant, this tryptamine is both psychedelic, stimulating and entactogenic. Related to α-MT, briefly popular as an RC in the 1980s but has seen limited use. Similar to αMT, αET is a serotonin releaser and may carry the risk of serotonin syndrome in overdose. Potentially neurotoxic.
Alephpsychedelicempathogenresearch chemicaltentativeThe first sulphur-containing phenethylamine">Phenethylamine to have been evaluated for CNS activity for Stimulant or Psychedelic purposes.
AyahuascapsychedelicempathogenA concoction made of two or more plants that contain at least an MAOI and DMT, the combination of which allows the DMT to work orally. Typically associated to south american cultures. Also, sometimes approximated synthetically by taking an external MAOI with extracted DMT. Causes intense, spiritually orientated hallucinogenic experiences.
Butylonepsychedelicstimulantresearch chemicalhabit formingempathogenEmpathogen and stimulant of the cathinone class.
Cyclo-Methiodroneempathogenstimulanthabit formingresearch chemicaltentativeEmpathogen with strong stimulant effects, very loosely related to benzylpiperidine.
Dimemebferesearch chemicalpsychedelicempathogententativeRelated in structure to 5-MeO-DMT, yet much less potent. Described as feeling somewhat similar to Mushrooms, with some empathogenic effects.
ETHYL-PENTEDRONEstimulantempathogententativeresearch chemicalA stimulant that came out around the same time as Ethyl-Hexedrone, not much information on it. Is in the cathinone family of substances. Related to Pentedrone.
Ethylonestimulantpsychedelicresearch chemicalhabit formingempathogenA euphoric stimulant often sold in place of MDMA since Methylone was banned. Slightly less potent and empathogenic than Methylone, it is often described as more of a 'straight stimulant.'
HOT-7psychedelicresearch chemicaltentativeempathogenA rather rare psychedelic phenylethylamine that is the hydroxylated version and prodrug for 2C-T-7.
MBDBstimulantresearch chemicaltentativeempathogenhabit formingA rare entactogenic drug and analogue of MDMA possibly first synthesised by David Nichols. Potentially less potent than related drugs of its type. Sometimes referred to as a 'watered down MDMA.'
MDApsychedelicstimulantempathogenhabit formingcommonA stimulant and empathogen. Similar to MDMA but typically produces more visuals than MDMA. Known to be more neurotoxic than MDMA, and is a minor metabolite of MDMA. Duration and onset similar to MDMA. The common Marquis reagent test cannot differentiate MDA and MDMA.
MDAIpsychedelicstimulantresearch chemicalhabit formingempathogenA selective serotonin releasing agent which is rarely used without a stimulant to gain desirable effects. Not believed to be neurotoxic.
MDEAstimulantempathogententativeA quite rare empathogen closely related to MDMA. Yet is less potent than the prior.
MDMAstimulantpsychedelicempathogenhabit formingcommonThe world's most popular empathogen with powerful pro-social effects. Has been strongly linked to cognitive decline in excess. Popular at parties, it is often sold in powder or in pills, and may be adulterated with other similar chemicals.
MDOHstimulantpsychedelicresearch chemicaltentativeempathogenhabit formingAn entactogen, stimulant and psychedelic first synthesised by Alexander Shulgin, MDOH is an analogue of MDA. Described as highly psychedelic, it is likely a serotonin releasing agent. It has not seen widespread use, perhaps due to a number of reported negative side effects such as urinary retention and a heavy comedown.
MDPAempathogenresearch chemicalhabit formingtentativeAn obscure substituted methylenedioxyphenethylamine with practically no history of human use. Its pharmacological profile is largely unknown, but potentially exhibits similar properties to other MDxx compounds. May be a monoamine releaser, reuptake inhibitor or both.
Mephedronestimulantresearch chemicalhabit formingempathogenA shortlived euphoric stimulant, developed as an analogue of MDMA, which was extremely popular in the research chemical scene before being banned. Commonly seen on street markets but rarer online. Very strong urge to redose compulsively.
4-MPMstimulantresearch chemicaltentativehabit formingempathogen4-Methylphenmetrazine is an empathogen of the phenylmorpholine class that seems to have a very rapid tolerance build up.
Methamnetaminepsychedelicstimulantresearch chemicaltentativeempathogenhabit formingA selective serotonin releaser, which also shows some light psychedelic activity. Almost always taken with a stimulant, to cause euphoric effects.
Methylonestimulantpsychedelicresearch chemicalhabit formingempathogencommonβk-MDMA is a cathinone stimulant and empathogen, similar in structure to MDMA, though more stimulating and less empathogenic in comparison. Was very commonly mis-sold as MDMA on the street until it was banned in 2013. The Marquis reagent can differentiate βk-MDMA from MDMA. Less potent than MDMA with a slightly shorter duration.
Mexedroneempathogenstimulantresearch chemicalhabit formingtentativeMexedrone is a stimulant drug of the cathinone class. It alters the reuptake of serotonin, dopamine, and norepinephrine to cause euphoria, and is similar in effects to Mephedrone. It is considered a designer drug and is in a legally grey area globally.
NM-2-AIstimulantempathogenStimulant that is in the aminoindane class. Is it quite close to it's bigger brother 2-AI. Yet this has a lower potency, has a longer duration though.
Psilocinpsychedelictentativeempathogenresearch chemicalPsilocin is a substutued tryptamine alkaloid, that is present in most psychedelic Mushrooms. It is relatively unstable in solution due to the -OH group.
YOPOempathogenpsychedelicAnadenanthera peregrina, also known as YOPO, is a perennial tree native to the Caribbean and South America. It is an entheogen containing 5-MeO-DMT and DMT, and is used in healing ceremonies and rituals. It is also a source of dietary calcium.

Factsheets on 53 drugs